海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688302 海创药业

已收盘 07-25 15:00:01

{"stockData":{"symbol":"688302","market":"SH","secType":"STK","nameCN":"海创药业","latestPrice":55.51,"timestamp":1753426801000,"preClose":58.34,"halted":0,"volume":5094871,"delay":0,"changeRate":-0.0485,"floatShares":81515100,"shares":99015600,"eps":-1.8622,"marketStatus":"已收盘","change":-2.83,"latestTime":"07-25 15:00:01","open":58.34,"high":60.2,"low":55.39,"amount":294000000,"amplitude":0.0824,"askPrice":55.51,"askSize":47,"bidPrice":55.5,"bidSize":22,"shortable":0,"etf":0,"ttmEps":-1.8622,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":58.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":64.17,"lowLimit":52.51,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":99015598,"isCdr":false,"pbRate":4.72,"roa":"--","roe":"--","epsLYR":-2.01,"committee":-0.35316,"marketValue":5496000000,"turnoverRate":0.0625,"status":1,"afterMarket":{"amount":0,"volume":0,"close":55.51,"buyVolume":0,"sellVolume":0,"time":1753428838020,"indexStatus":"已收盘 07-25 15:30:00","preClose":58.34},"floatMarketCap":4525000000},"requestUrl":"/m/hq/s/688302","defaultTab":"news","newsList":[{"id":"2553239066","title":"7月22日海创药业现513万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2553239066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553239066?lang=zh_cn&edition=full","pubTime":"2025-07-22 17:32","pubTimestamp":1753176753,"startTime":"0","endTime":"0","summary":"证券之星消息，7月22日海创药业发生大宗交易，交易数据如下：大宗交易成交价格51.3元，相对当日收盘价折价8.06%，成交10万股，成交金额513万元，买方营业部为广发证券股份有限公司宝鸡公园路证券营业部，卖方营业部为中信证券股份有限公司四川分公司。近三个月该股共发生5笔大宗交易，合计成交3750.0手，折价成交5笔。截至2025年7月22日收盘，海创药业报收于55.8元，上涨0.11%，换手率6.56%，成交量5.34万手，成交额3.07亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200028557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2552173534","title":"每周股票复盘：海创药业（688302）大宗交易频繁，折价率高","url":"https://stock-news.laohu8.com/highlight/detail?id=2552173534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552173534?lang=zh_cn&edition=full","pubTime":"2025-07-20 03:12","pubTimestamp":1752952335,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，海创药业报收于57.1元，较上周的48.91元上涨16.75%。本周，海创药业7月18日盘中最高价报57.57元。7月14日盘中最低价报48.21元。海创药业当前最新总市值56.54亿元，在化学制药板块市值排名91/150，在两市A股市值排名2765/5149。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2552107704","title":"7月17日海创药业现1笔折价12.52%的大宗交易 合计成交715.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552107704","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552107704?lang=zh_cn&edition=full","pubTime":"2025-07-17 17:20","pubTimestamp":1752744052,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日海创药业发生大宗交易，交易数据如下：近三个月该股共发生3笔大宗交易，合计成交2040.0手，折价成交3笔。该股在过去半年内已有共计879.07万股限售解禁股上市，占公司总股本的8.88%。截至2025年7月17日收盘，海创药业报收于54.31元，上涨3.45%，换手率6.13%，成交量4.99万手，成交额2.67亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700026970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2551123058","title":"“降压药王”无缘集采，仿制药企的日子更不好过了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2551123058","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551123058?lang=zh_cn&edition=full","pubTime":"2025-07-16 20:55","pubTimestamp":1752670558,"startTime":"0","endTime":"0","summary":"沙库巴曲缬沙坦无缘集采，诺华应该可以松一口气，但这些仿制药企要失望了。“降压药王”出局因专利原因无缘集采的品种中，沙库巴曲缬沙坦可能是最受市场期待的一个。不过，声明并没能阻止仿制药的上市销售。几家欢喜几家愁沙库巴曲缬沙坦未能入围第11批集采，对这个品种的数十家仿制药企不是好消息。截至目前，已经有九典制药等四家药企的吲哚布芬片仿制品种因专利纠纷被暂停销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716212356a6ad9ce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716212356a6ad9ce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2551119280","title":"科创成长层改革推进 券商系统升级及风险揭示书签署有序展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119280","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119280?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:13","pubTimestamp":1752635582,"startTime":"0","endTime":"0","summary":"上交所方面正组织风险揭示书签署工作，并修订相关指南，新增《科创板科创成长层企业股票投资风险揭示书必备条款》，明确未盈利企业存在的各类投资风险。上交所下发通知要求券商完善适当性管理工作，包括完成风险揭示书签署及系统准备，给予投资者充分阅读时间，并通过多种渠道开展投资者教育。上交所将持续督促券商并开展监督检查。7月14日，上交所举办专题培训会，120家券商330余名相关负责人参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688327","688343","688221","688322","688176","688382","688192","688302","01877","688373","06160","688197","02402","688220","688316","688266","688702","688512","BK0239","688165","000690.SH","688280","688538","09969","688549","688515","688277","688561","688256","688469","ONC","688443","688387"],"gpt_icon":0},{"id":"2551168565","title":"7月15日海创药业现1笔折价10.26%的大宗交易 合计成交252.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551168565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551168565?lang=zh_cn&edition=full","pubTime":"2025-07-15 17:20","pubTimestamp":1752571242,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日海创药业发生大宗交易，交易数据如下：大宗交易成交价格46.71元，相对当日收盘价折价10.26%，成交5.4万股，成交金额252.23万元，买方营业部为中信证券股份有限公司徐州建国西路证券营业部，卖方营业部为中信证券股份有限公司四川分公司。近三个月该股共发生1笔大宗交易，合计成交540.0手，折价成交1笔。截至2025年7月15日收盘，海创药业报收于52.05元，上涨0.29%，换手率4.11%，成交量3.35万手，成交额1.73亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500029455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2551927029","title":"肿瘤治疗概念盘中拉升，亚虹医药-U等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927029?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:17","pubTimestamp":1752459467,"startTime":"0","endTime":"0","summary":"07月14日，肿瘤治疗概念盘中拉升，截至10点17分，肿瘤治疗概念整体指数上涨1.05%，报1594.390点。从个股上来看，该概念的成分股中，莱美药业涨幅超过10%，亚虹医药-U等2只股票涨停，海创药业-U、冠昊生物2只股涨幅超过5%。从资金上来看，截止发稿，肿瘤治疗概念主力净流入为-2.46亿，其中广生堂受到资金热捧，主力净流入5981.97万；拉长时间线来看，该板块近20日主力资金净流入-63.27亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410174795417a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410174795417a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239","688302"],"gpt_icon":0},{"id":"2551927070","title":"海创药业-U涨5.05% 创新药研发预期提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927070","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927070?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:16","pubTimestamp":1752459373,"startTime":"0","endTime":"0","summary":"海创药业-U今日股价大幅上涨，截至10点15分，最新价报51.38元/股，涨幅达5.05%。资金博弈与情绪共振引发波动海创药业-U近期股价波动与短期资金面博弈密切相关。化学制药板块6月25日至30日累计净流出14.45亿元，避险情绪压制板块流动性。叠加股东盈创动力7月8日减持28万股，年内近60%涨幅触发部分资金获利了结，筹码松动加剧波动。技术转化与政策红利重构估值逻辑长期看，海创药业-U股价走势将取决于核心管线进展及技术转化能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714101622a448b8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714101622a448b8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","159992","BK0239"],"gpt_icon":0},{"id":"2549154663","title":"海创药业：盈创动力累计减持0.28%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2549154663","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549154663?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:26","pubTimestamp":1751970404,"startTime":"0","endTime":"0","summary":"格隆汇7月8日丨海创药业(688302.SH)公布，公司于2025年7月8日收到成都盈创动力创业投资有限公司（以下简称“盈创动力”）发来的《关于股份减持暨权益变动触及1%的告知函》。截至2025年7月8日，盈创动力通过集中竞价交易方式累计减持公司股份276,133股，占公司总股本的0.28%，持股比例由6.28%减少至6.00%，变动触及6.00%，适用变动触及1%的整数倍情形。截至目前，减持计划尚未实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708182655979e3503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708182655979e3503&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2548821048","title":"海创药业-U涨5.05% 技术转化预期提振估值博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821048","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548821048?lang=zh_cn&edition=full","pubTime":"2025-07-03 13:20","pubTimestamp":1751520017,"startTime":"0","endTime":"0","summary":"海创药业-U今日股价大幅上涨，截至13点19分，最新价为49.50元/股，涨幅达5.05%。资金博弈加剧估值分歧海创药业-U近期净流出与资金面波动密切相关。截至7月3日，该股年内累计涨幅达61.19%，动态市盈率-38.17的估值特征引发多空博弈。技术转化预期主导价值中枢长期来看，海创药业-U的估值锚点系于核心管线商业化进程。当前4.21倍市净率低于科创板医药企业均值，但核心产品获批前仍需警惕研发风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703132021a4cc8f39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703132021a4cc8f39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2546788383","title":"海创药业-U06月26日遭主力抛售642.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546788383","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546788383?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:21","pubTimestamp":1750922484,"startTime":"0","endTime":"0","summary":"06月26日, 海创药业-U股价跌3.83%，报收46.15元，成交金额1.7亿元，换手率4.59%，振幅6.40%，量比1.30。海创药业-U今日主力资金净流出642.7万元，连续6日净流出，上一交易日主力净流出1264.5万元。|06月26日主力加仓幅度排名||#|股票简称|主力净额占比|#|欢瑞世纪|6.52%|#|华锋股份|6.02%|#|科创信息|5.98%|#|...|...|#4061|海创药业-U|-0.17%|海创药业-U所在的化学制药行业，今日主力净流出16.11亿元，行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626165915a4bedd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626165915a4bedd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2545440262","title":"海创药业-U06月24日遭主力抛售1288.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545440262","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545440262?lang=zh_cn&edition=full","pubTime":"2025-06-24 15:21","pubTimestamp":1750749670,"startTime":"0","endTime":"0","summary":"06月24日, 海创药业-U股价跌0.77%，报收47.94元，成交金额1.6亿元，换手率4.15%，振幅4.14%，量比1.08。海创药业-U今日主力资金净流出1288.7万元，连续4日净流出，上一交易日主力净流出244.6万元。该股近5个交易日下跌4.22%，主力资金累计净流出4181.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2.2亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624170438a71aeb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624170438a71aeb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2544158128","title":"【首发】海创药业Ⅰ类抗癌新药氘恩扎鲁胺软胶囊实现全国上市首发和首张处方","url":"https://stock-news.laohu8.com/highlight/detail?id=2544158128","media":"海创药业","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544158128?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:53","pubTimestamp":1750406022,"startTime":"0","endTime":"0","summary":"海纳百安美好新生INTERNET氘恩扎鲁胺软胶囊全国上市首发开具全国首张处方股票代码：688302.SH6月20日，海创药业自主研发的Ⅰ类抗癌新药氘恩扎鲁胺软胶囊(海纳安)首批产品从广州装车发货，并于今日开出全国首张处方！作为海创药业首款获批上市的Ⅰ类抗癌新药产品，首方的开出距离该药获批上市仅半月余，充分展现了其重要的临床价值和紧迫的临床需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620172547a4b45086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620172547a4b45086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2544128151","title":"海创药业-U06月20日遭主力抛售1014.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544128151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544128151?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:21","pubTimestamp":1750404087,"startTime":"0","endTime":"0","summary":"06月20日, 海创药业-U股价跌2.36%，报收47.65元，成交金额1.1亿元，换手率2.84%，振幅3.93%，量比0.62。海创药业-U今日主力资金净流出1014.3万元，上一交易日主力净流出1809.7万元。该股近5个交易日下跌8.84%，主力资金累计净流出3386.0万元；近20日主力资金累计净流出2.4亿元，其中净流出天数为14日。|06月20日主力加仓幅度排名||#|股票简称|主力净额占比|#|N华之杰|25.53%|#|N新恒汇|25.40%|#|川润股份|8.72%|#|...|...|#4538|海创药业-U|-0.26%|海创药业-U所在的化学制药行业，今日主力净流入2.16亿元，行业排名14/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620171215a714319b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620171215a714319b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2544920656","title":"海创药业-U06月18日主力净流入175.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544920656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544920656?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:21","pubTimestamp":1750231307,"startTime":"0","endTime":"0","summary":"06月18日, 海创药业-U股价涨1.70%，报收50.90元，成交金额1.3亿元，换手率3.17%，振幅4.60%，量比0.59。海创药业-U今日主力资金净流入175.9万元，上一交易日主力净流出1624.2万元。该股近5个交易日下跌8.32%，主力资金累计净流出1628.8万元；近20日主力资金累计净流出1.9亿元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618171520a4b037bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618171520a4b037bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2544932235","title":"海创药业-U大跌5% 近半年2家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2544932235","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544932235?lang=zh_cn&edition=full","pubTime":"2025-06-17 13:17","pubTimestamp":1750137462,"startTime":"0","endTime":"0","summary":"06月17日，海创药业-U股价大幅下跌，截至13点17分，海创药业-U下跌5.02%，报50.51元/股，成交2.06亿元，换手率4.79%，振幅7.97%。此外，数据统计显示，近半年内2家券商给予增持建议。资金动向截止发稿，海创药业-U获得主力净流出1956万元，其中超大单流出1724万元，大单流出230万元。融资融券方面，海创药业-U06月13日获得融资净买入1289万元，当日该股融资余额为1.55亿元，当较前一日增加9.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617131816a70d8d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617131816a70d8d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2543613345","title":"从Arvinas到海创：PROTAC技术商业化提速，海创药业首款药物获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2543613345","media":"CCTIME飞象网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543613345?lang=zh_cn&edition=full","pubTime":"2025-06-15 21:45","pubTimestamp":1749995100,"startTime":"0","endTime":"0","summary":"PROTAC技术利用双功能小分子靶向降解目标蛋白，是生物医药领域的革命性突破。海创药业自主研发的PROTAC药物HP518临床进展加速，充分彰显公司技术平台的前瞻布局与商业化潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061522132297809bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061522132297809bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2543730275","title":"媒体视角 | 5款国家一类新药同日获批 科创板创新药企步入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2543730275","media":"诚通证券财富管理","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543730275?lang=zh_cn&edition=full","pubTime":"2025-06-13 11:03","pubTimestamp":1749783819,"startTime":"0","endTime":"0","summary":"5月29日，国家药监局集中发布11款新药上市批件，科创板创新药企表现亮眼，强势占据其中5席。本次集中获批是科创板创新药企研发管线加速落地的缩影。在新药上市申请受理一端，科创板今年亦是佳音不断。根据公开信息，该笔交易创下国产创新药出海首付款金额的历史新高，达成了国内药企迈向全球市场的又一里程碑，充分体现了国际市场对科创板创新药研发实力的高度认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613111055a7068aef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613111055a7068aef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","688278","688302","06160","688062","BK4139","688235","ONC","688266"],"gpt_icon":0},{"id":"2543578460","title":"海创药业-U大跌5% 近半年2家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2543578460","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543578460?lang=zh_cn&edition=full","pubTime":"2025-06-13 10:17","pubTimestamp":1749781051,"startTime":"0","endTime":"0","summary":"06月13日，海创药业-U股价大幅下跌，截至10点17分，海创药业-U下跌5.03%，报53.62元/股，成交1.04亿元，换手率2.30%。此外，数据统计显示，近半年内2家券商给予增持建议。资金动向截止发稿，海创药业-U获得主力净流出888万元，其中超大单流出780万元，大单流出106万元。最新财报显示，今年一季报，海创药业-U实现营业收入0.00元，同比减少-%，净利润为-3,210.18万元，同比增长32.01%，基本每股收益为-0.32元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613101758a4a65715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613101758a4a65715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2542219301","title":"海创药业-U06月11日遭主力抛售2664.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542219301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542219301?lang=zh_cn&edition=full","pubTime":"2025-06-11 15:20","pubTimestamp":1749626459,"startTime":"0","endTime":"0","summary":"06月11日, 海创药业-U股价跌3.48%，报收55.52元，成交金额2.6亿元，换手率5.68%，振幅4.64%，量比0.71。海创药业-U今日主力资金净流出2664.3万元，上一交易日主力净流出269.0万元。该股近5个交易日上涨16.49%，主力资金累计净流出2424.8万元；近20日主力资金累计净流出1.6亿元，其中净流出天数为12日。|06月11日主力加仓幅度排名||#|股票简称|主力净额占比|#|N影石|34.70%|#|兆日科技|5.99%|#|哈尔斯|5.52%|#|...|...|#5151|海创药业-U|-0.59%|海创药业-U所在的化学制药行业，今日主力净流出15.80亿元，行业排名1/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611171146a4a33e73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611171146a4a33e73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753456683442,"stockEarnings":[{"period":"1week","weight":0.0742},{"period":"1month","weight":0.2169},{"period":"3month","weight":0.5296},{"period":"6month","weight":1.0103},{"period":"1year","weight":1.3979},{"period":"ytd","weight":0.8997}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海创药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4193人(较上一季度增加25.09%)","perCapita":"19440股","listingDate":"2022-04-12","address":"四川省成都市武侯区高新区科园南路5号蓉药大厦1栋4层附2、3号","registeredCapital":"9901万元","survey":"　　海创药业股份有限公司的主营业务是肿瘤、代谢性疾病等重大治疗领域的创新药物研发。公司的主要产品是HC-1119、HP518（PROTAC）、HP568（PROTAC）、HP537、HP560、HP501、HP515。公司荣获“2024年成都市企业技术中心”，“2024中国医药研发排行榜化药榜单前100强”，“成都市高新区“金熊猫未来星”·企业关键核心技术奖”等荣誉及称号。","listedPrice":42.92},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海创药业,688302,海创药业股票,海创药业股票老虎,海创药业股票老虎国际,海创药业行情,海创药业股票行情,海创药业股价,海创药业股市,海创药业股票价格,海创药业股票交易,海创药业股票购买,海创药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}